Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study

Table 4 Comparison of the alpha-fetoprotein level distributions in patients with and without hepatocellular carcinoma, n (%)

AFP (μg/L)	No-HCC group (n = 145)	HCC group (n = 121)	P value
< 20	128 (88.27)	65 (53.72)	< 0.001
20-100	12 (8.27)	14 (11.57)	0.51
100-200	1 (0.69)	2 (2.17)	0.231
200-400	2 (1.38)	3 (2.48)	1
≥ 400	2 (1.38)	37 (30.58)	< 0.001

AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma.